title: Is IL-4 a potential therapeutic target in systemic sclerosis-associated pulmonary fibrosis?
authors: Petros P
authors: PP
authors: Sfikakis
mesh_terms: D001549:Benzamides; D001992:Bronchoalveolar Lavage Fluid / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects*; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D015847:Interleukin-4 / Q000276:immunology*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
chemical_list: D001549:Benzamides; C508598:IL4 protein, human; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D015847:Interleukin-4; D000068877:Imatinib Mesylate